[211At]meta-astatobenzylguanidine ([211At]MABG)

N/A

Report date: 2025/11/27 17:57:18
NME

Base Information

Drug Name[211At]meta-astatobenzylguanidine ([211At]MABG)
Drug Alias Name[211At]MABG
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsUpdating
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of PennsylvaniaChildrens Hospital of Philadelphia
China Registration ClassN/A

Develop Information

Active CompaniesChildrens Hospital of PhiladelphiaUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A